Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients

por Noon, A P, Albertsen, P C, Thomas, F, Rosario, D J, Catto, J W F
Publicado 2013

Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis

por Blick, C, Ramachandran, A, McCormick, R, Wigfield, S, Cranston, D, Catto, J, Harris, A L
Publicado 2015

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer

por Calvert, N W, Morgan, A B, Catto, J W F, Hamdy, F C, Akehurst, R L, Mouncey, P, Paisley, S
Publicado 2003

Changes in circulating microRNA levels associated with prostate cancer

por Bryant, R J, Pawlowski, T, Catto, J W F, Marsden, G, Vessella, R L, Rhees, B, Kuslich, C, Visakorpi, T, Hamdy, F C
Publicado 2012

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer

por Miah, S, Dudziec, E, Drayton, R M, Zlotta, A R, Morgan, S L, Rosario, D J, Hamdy, F C, Catto, J W F
Publicado 2012

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors

por Rehman, I, Cross, S S, Azzouzi, A-R, Catto, J W F, Deloulme, J C, Larre, S, Champigneuille, J, Fromont, G, Cussenot, O, Hamdy, F C
Publicado 2004

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer

por Blick, C, Ramachandran, A, Wigfield, S, McCormick, R, Jubb, A, Buffa, F M, Turley, H, Knowles, M A, Cranston, D, Catto, J, Harris, A L
Publicado 2013

Telemedicina y trabajo inteligente: adaptación al español de las recomendaciones de la Asociación Europea de Urología

por Gómez Rivas, J., Rodríguez-Serrano, A., Loeb, S., Yuen-Chun Teoh, J., Ribal, M.J., Bloemberg, J., Catto, J., ŃDow, J., van Poppel, H., González, J., Esteban, M., Rodriguez Socarrás, M.
Publicado 2020

Telemedicine and smart working: Spanish adaptation of the European Association of Urology recommendations()

por Gómez Rivas, J., Rodríguez-Serrano, A., Loeb, S., Yuen-Chun Teoh, J., Ribal, M.J., Bloemberg, J., Catto, J., N’Dow, J., van Poppel, H., González, J., Esteban, M., Rodriguez Socarrás, M.
Publicado 2020

Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden

por Cazier, J.-B., Rao, S.R., McLean, C.M., Walker, A.L., Wright, B.J., Jaeger, E.E.M., Kartsonaki, C., Marsden, L., Yau, C., Camps, C., Kaisaki, P., Taylor, J., Catto, J.W., Tomlinson, I.P.M., Kiltie, A.E., Hamdy, F.C.
Publicado 2014

Corrigendum: Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden

por Cazier, J. -B., Rao, S. R., McLean, C. M., Walker, A. K., Wright, B. J., Jaeger, E. E. M., Kartsonaki, C., Marsden, L., Yau, C., Camps, C., Kaisaki, P., Taylor, J., Catto, J. W., Tomlinson, I. P. M., Kiltie, A. E., Hamdy, F. C.
Publicado 2014

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

por Catto, J W F, Robinson, M C, Albertsen, P C, Goepel, J R, Abbod, M F, Linkens, D A, Davis, M, Rosario, D J, Warren, A Y, Varma, M, Griffiths, D F, Grigor, K M, Mayer, N J, Oxley, J D, Deshmukh, N S, Lane, J A, Metcalfe, C, Donovan, J L, Neal, D E, Hamdy, F C
Publicado 2011